Impedimed Property Plant Equipment vs Other Current Liab Analysis
IPD Stock | 0.04 0 2.50% |
Impedimed financial indicator trend analysis is infinitely more than just investigating Impedimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impedimed is a good investment. Please check the relationship between Impedimed Property Plant Equipment and its Other Current Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Property Plant Equipment vs Other Current Liab
Property Plant Equipment vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impedimed Property Plant Equipment account and Other Current Liab. At this time, the significance of the direction appears to have no relationship.
The correlation between Impedimed's Property Plant Equipment and Other Current Liab is 0.03. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Impedimed, assuming nothing else is changed. The correlation between historical values of Impedimed's Property Plant Equipment and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Impedimed are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Property Plant Equipment i.e., Impedimed's Property Plant Equipment and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.03 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Property Plant Equipment
Other Current Liab
Most indicators from Impedimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. Tax Provision is likely to gain to about 40.3 K in 2025, whereas Selling General Administrative is likely to drop slightly above 13.6 M in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Cost Of Revenue | 25.0M | 1.3M | 1.5M | 1.4M | Total Revenue | 11.3M | 10.3M | 11.9M | 12.5M |
Impedimed fundamental ratios Correlations
Click cells to compare fundamentals
Impedimed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Impedimed fundamental ratios Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 34.2M | 58.7M | 68.7M | 47.0M | 54.0M | 37.4M | |
Other Current Liab | 5.6M | 3.5M | 3.2M | 3.2M | 3.7M | 3.0M | |
Total Current Liabilities | 8.1M | 7.2M | 5.8M | 4.7M | 5.4M | 4.8M | |
Other Liab | 87K | 398K | 413K | 864K | 993.6K | 1.0M | |
Accounts Payable | 1.3M | 2.6M | 1.4M | 1.1M | 1.3M | 1.4M | |
Net Receivables | 2.8M | 2.7M | 2.6M | 2.2M | 2.5M | 1.4M | |
Good Will | 2.4M | 2.6M | 2.7M | 2.7M | 3.1M | 2.5M | |
Inventory | 372K | 926K | 810K | 759K | 683.1K | 912.9K | |
Other Current Assets | 2.8M | 2.3M | 2.8M | 1.9M | 2.2M | 1.7M | |
Total Liab | 8.7M | 7.7M | 7.9M | 6.2M | 7.2M | 5.2M | |
Intangible Assets | 7.5M | 11.4M | 14.8M | 13.3M | 15.3M | 16.1M | |
Common Stock | 267.3M | 307.6M | 336.1M | 336.1M | 386.6M | 405.9M | |
Property Plant Equipment | 1.0M | 418K | 2.0M | 1.4M | 1.7M | 1.7M | |
Short Long Term Debt Total | 474K | 170K | 1.4M | 1.1M | 1.3M | 799.6K | |
Total Stockholder Equity | 25.5M | 51.0M | 60.9M | 40.7M | 46.9M | 34.4M | |
Property Plant And Equipment Net | 1.0M | 418K | 2.0M | 1.4M | 1.7M | 1.7M | |
Net Debt | (19.2M) | (40.6M) | (44.3M) | (23.5M) | (21.1M) | (22.2M) | |
Retained Earnings | (270.8M) | (290.6M) | (311.2M) | (331.0M) | (297.9M) | (283.0M) | |
Cash | 19.7M | 40.7M | 45.7M | 24.6M | 28.3M | 28.3M | |
Non Current Assets Total | 8.6M | 12.0M | 16.8M | 17.5M | 20.2M | 21.2M | |
Non Currrent Assets Other | (8.6M) | (11.9M) | (16.8M) | 13.3M | 12.0M | 12.6M | |
Cash And Short Term Investments | 19.7M | 40.7M | 45.7M | 24.6M | 28.3M | 28.3M | |
Common Stock Shares Outstanding | 1.2B | 1.7B | 1.8B | 2.0B | 2.3B | 2.4B | |
Liabilities And Stockholders Equity | 34.2M | 58.7M | 68.7M | 47.0M | 54.0M | 39.2M | |
Non Current Liabilities Total | 557K | 413K | 2.0M | 1.6M | 1.8M | 1.9M | |
Property Plant And Equipment Gross | 3.4M | 3.8M | 5.6M | 5.7M | 6.5M | 6.8M | |
Total Current Assets | 25.7M | 46.7M | 51.9M | 29.5M | 33.9M | 32.8M | |
Accumulated Other Comprehensive Income | 29.0M | 34.1M | 36.0M | 35.5M | 40.9M | 42.9M | |
Short Term Debt | (562K) | (758K) | 141K | 333K | 299.7K | 314.7K | |
Net Tangible Assets | 20.8M | 18.1M | 39.7M | 46.1M | 41.5M | 28.0M | |
Current Deferred Revenue | 877K | 928K | 1.0M | 1.5M | 1.7M | 1.8M | |
Long Term Investments | 73K | 75K | 78K | 54K | 48.6K | 62.5K | |
Net Invested Capital | 25.5M | 51.0M | 60.9M | 40.7M | 46.9M | 43.5M | |
Cash And Equivalents | 11.5M | 31.3M | 13.5M | 18.4M | 16.5M | 16.7M | |
Net Working Capital | 17.5M | 39.4M | 46.1M | 24.8M | 22.3M | 24.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.